1408282-63-2

Upstream product

• 540-88-5 acetic acid tert-butyl ester 
• 98-68-0 4-methoxy-phenyl-sulphonyl chloride 
• 75190-94-2 (2S)-2-amino-butanoic acid t-butyl ester 

Downstream Products

• 440648-30-6 (S)-N-(4-Methoxyphenylsulfonyl)-N-(3-pyridylmethyl)-aminobutanoic acid 
• 1408282-76-7 tert-butyl (S)-N-(4-methoxyphenylsulfonyl)-N-(3-pyridylmethyl)-2-aminobutanoate 
• 1408282-86-9 (S)-N-(4-methoxyphenylsulfonyl)-N-(3-pyridylmethyl)-2-aminobutanoic acid 
• 1408282-94-9 O-tert-butyl (S)-N₂-(4-methoxyphenylsulfonyl)-N₂-(3-pyridylmethyl)-2-aminobutanehydroxamate 
• 1408283-02-2 (S)-N₂-(4-methoxyphenylsulfonyl)-N₂-(3-pyridylmethyl)-2-aminobutanehydroxamic acid 

Relevant academic research and scientific papers

New matrix metalloproteinase inhibitors based on γ-fluorinated α-aminocarboxylic and α-aminohydroxamic acids

Abstract Matrix metalloproteinases (MMPs) are involved in a number of physiological as well as pathological processes such as atherosclerosis and tumorigenesis, where an up-regulation of MMPs is predominant. Fluorinated analogues of the hydroxamate-based

Compounds with Matrix-Metalloproteinase Inhibitory Activity and Imaging Agents Thereof

The present invention relates to the field of therapeutic and diagnostic agents and more specifically to compounds of formula (I) that are inhibitors of matrix-metalloproteinases (MMPs) and are useful in the treatment of diseases related thereto such as c